Kestra Medical Technologies Ltd. Common Stock (KMTS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kestra Medical Technologi...

    NASDAQ: KMTS · Real-Time Price · USD
    17.00
    0.49 (2.97%)
    At close: Sep 05, 2025, 3:59 PM
    17.34
    2.00%
    After-hours: Sep 05, 2025, 07:26 PM EDT

    Kestra Medical Common Stock Income Statement

    Financials in USD. Fiscal year is May - April.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023
    Revenue
    		 59.81M 27.81M 7.63M
    Cost of Revenue
    		 35.6M 27.45M 18.28M
    Gross Profit
    		 24.21M 362K -10.65M
    Operating Income
    		 -106.38M -85.06M -80.42M
    Interest Income
    		 3.2M n/a n/a
    Pretax Income
    		 -113.68M -94.1M -84.22M
    Net Income
    		 -113.81M -94.12M -84.24M
    Selling & General & Admin
    		 114.94M 69.94M 54.01M
    Research & Development
    		 15.65M 15.49M 15.76M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 130.59M 85.42M 69.77M
    Interest Expense
    		 7.73M 6.23M 5.63M
    Selling & Marketing Expenses
    		 n/a 40.68M 34.92M
    Cost & Expenses
    		 166.19M 112.88M 88.05M
    Income Tax Expense
    		 135K 24K 15K
    Shares Outstanding (Basic)
    		 49.53M 49.53M 49.53M
    Shares Outstanding (Diluted)
    		 49.53M 49.53M 49.53M
    EPS (Basic)
    		 -5.13 -2.04 -1.75
    EPS (Diluted)
    		 -5.13 -2.04 -1.75
    EBITDA
    		 -97.98M -76.31M -73.74M
    EBIT
    		 -105.94M -87.87M -78.59M
    Depreciation & Amortization
    		 7.97M 11.56M 4.86M

    Add to Watchlist